Cita APA

Wu, H., Hu, C., Wang, A., Weisberg, E. L., Wang, W., Chen, C., . . . Liu, Q. (2015). Ibrutinib Selectively Targets FLT3-ITD in Mutant FLT3-Positive AML. Leukemia.

Citación estilo Chicago

Wu, Hong, et al. "Ibrutinib Selectively Targets FLT3-ITD in Mutant FLT3-Positive AML." Leukemia 2015.

Cita MLA

Wu, Hong, et al. "Ibrutinib Selectively Targets FLT3-ITD in Mutant FLT3-Positive AML." Leukemia 2015.